Dextran 75 (AnazaoHealth Corporation)
Welcome to the PulseAid listing for the Dextran 75 drug offered from AnazaoHealth Corporation. This Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AnazaoHealth Corporation |
NON-PROPRIETARY NAME: | Dextran 75 |
SUBSTANCE NAME: | DEXTRAN 75 |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2012-07-01 |
END MARKETING DATE: | 0000-00-00 |
Dextran 75 HUMAN PRESCRIPTION DRUG Details:
Item Description | Dextran 75 from AnazaoHealth Corporation |
LABELER NAME: | AnazaoHealth Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2012-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51808-210_29c1fd45-7d77-4882-9e73-8a66742be742 |
PRODUCT NDC: | 51808-210 |
APPLICATION NUMBER: | |
Other DEXTRAN 75 Pharmaceutical Manufacturers / Labelers: